002693 *ST双成
已收盘 04-30 15:00:00
资讯
新帖
简况
*ST双成（002693）2026年一季报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 04-30 06:36
*ST双成（002693）2026年一季报简析：营收净利润同比双双增长，应收账款上升
异动快报：*ST双成（002693）4月29日10点37分触及跌停板
证券之星 · 04-29
异动快报：*ST双成（002693）4月29日10点37分触及跌停板
图解*ST双成一季报：第一季度单季净利润同比增长134.34%
证券之星 · 04-29
图解*ST双成一季报：第一季度单季净利润同比增长134.34%
*ST双成（002693）披露2026年一季度报告，4月28日股价上涨3.07%
证券之星 · 04-28
*ST双成（002693）披露2026年一季度报告，4月28日股价上涨3.07%
*ST双成（002693）披露关于申请撤销退市风险警示的公告，4月20日股价上涨1.41%
中金财经 · 04-20
*ST双成（002693）披露关于申请撤销退市风险警示的公告，4月20日股价上涨1.41%
*ST双成（002693）2025年年报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 04-19
*ST双成（002693）2025年年报简析：营收净利润同比双双增长，应收账款上升
*ST双成(002693)3月31日股东户数3.22万户，较上期减少16.75%
证券之星 · 04-18
*ST双成(002693)3月31日股东户数3.22万户，较上期减少16.75%
图解*ST双成年报：第四季度单季净利润同比增长153.29%
证券之星 · 04-18
图解*ST双成年报：第四季度单季净利润同比增长153.29%
*ST双成(002693.SZ)：2025年净利润1904.32万元
中金财经 · 04-17
*ST双成(002693.SZ)：2025年净利润1904.32万元
*ST双成（002693）披露公司股票可能被终止上市的第六次风险提示性公告，4月16日股价上涨0.36%
证券之星 · 04-16
*ST双成（002693）披露公司股票可能被终止上市的第六次风险提示性公告，4月16日股价上涨0.36%
*ST双成（002693）披露公司股票可能被终止上市的第五次风险提示性公告，4月3日股价下跌3.27%
证券之星 · 04-03
*ST双成（002693）披露公司股票可能被终止上市的第五次风险提示性公告，4月3日股价下跌3.27%
异动快报：*ST双成（002693）3月24日9点37分触及涨停板
证券之星 · 03-24
异动快报：*ST双成（002693）3月24日9点37分触及涨停板
*ST双成（002693）披露召开2026年第二次临时股东大会通知，3月23日股价下跌4.04%
证券之星 · 03-23
*ST双成（002693）披露召开2026年第二次临时股东大会通知，3月23日股价下跌4.04%
*ST双成（002693）披露2025年年度报告编制及最新审计进展情况公告，3月20日股价下跌1.98%
证券之星 · 03-20
*ST双成（002693）披露2025年年度报告编制及最新审计进展情况公告，3月20日股价下跌1.98%
异动快报：*ST双成（002693）3月18日10点59分触及涨停板
证券之星 · 03-18
异动快报：*ST双成（002693）3月18日10点59分触及涨停板
*ST双成（002693）披露公司股票可能被终止上市的第四次风险提示性公告，3月17日股价下跌2.86%
证券之星 · 03-17
*ST双成（002693）披露公司股票可能被终止上市的第四次风险提示性公告，3月17日股价下跌2.86%
异动快报：*ST双成（002693）3月16日13点25分触及涨停板
证券之星 · 03-16
异动快报：*ST双成（002693）3月16日13点25分触及涨停板
异动快报：*ST双成（002693）3月13日9点32分触及涨停板
证券之星 · 03-13
异动快报：*ST双成（002693）3月13日9点32分触及涨停板
*ST双成（002693）披露公司股票可能被终止上市的第三次风险提示性公告，3月3日股价下跌3.11%
证券之星 · 03-03
*ST双成（002693）披露公司股票可能被终止上市的第三次风险提示性公告，3月3日股价下跌3.11%
*ST双成：公司目前没有生物方面的研究
证券之星 · 01-29
*ST双成：公司目前没有生物方面的研究
加载更多
公司概况
公司名称：
海南双成药业股份有限公司
所属行业：
医药制造业
上市日期：
2012-08-08
主营业务：
海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用紫杉醇（白蛋白结合型）、注射用胸腺法新、注射用生长抑素、注射用比伐芦定、依替巴肽注射液、醋酸奥曲肽注射液。
发行价格：
20.00
{"stockData":{"symbol":"002693","market":"SZ","secType":"STK","nameCN":"*ST双成","latestPrice":8.58,"timestamp":1777532619000,"preClose":8.61,"halted":0,"volume":13182400,"delay":0,"changeRate":-0.0035,"floatShares":411000000,"shares":415000000,"eps":0.0785,"marketStatus":"已收盘","change":-0.03,"latestTime":"04-30 15:00:00","open":8.53,"high":8.74,"low":8.43,"amount":113000000,"amplitude":0.036,"askPrice":8.59,"askSize":989,"bidPrice":8.58,"bidSize":260,"shortable":0,"etf":0,"ttmEps":0.0785,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778031000000},"marketStatusCode":5,"adr":0,"adjPreClose":8.61,"symbolType":"stock","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":9.04,"lowLimit":8.18,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":414689750,"isCdr":false,"pbRate":8.58,"roa":"--","peRate":109.299363,"roe":"0.83%","epsLYR":0.05,"committee":-0.079446,"marketValue":3558000000,"turnoverRate":0.0321,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-05-06。","floatMarketCap":3526000000},"requestUrl":"/m/hq/s/002693","defaultTab":"news","newsList":[{"id":"2631520205","title":"*ST双成（002693）2026年一季报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631520205","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631520205?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:36","pubTimestamp":1777502175,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期*ST双成发布2026年一季报。截至本报告期末，公司营业总收入4843.99万元，同比上升32.08%，归母净利润344.82万元，同比上升134.34%。本报告期*ST双成应收账款上升，应收账款同比增幅达296.13%。去年的净利率为3.22%，算上全部成本后，公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000022014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631255435","title":"异动快报：*ST双成（002693）4月29日10点37分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2631255435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631255435?lang=zh_cn&edition=full","pubTime":"2026-04-29 10:42","pubTimestamp":1777430560,"startTime":"0","endTime":"0","summary":"证券之星4月29日盘中消息，10点37分*ST双成触及跌停板。其所属行业化学制药目前上涨。领涨股为广生堂。该股为海南概念，肝炎概念，阿尔茨海默病概念热股，当日海南概念概念上涨0.78%，肝炎概念概念上涨0.64%，阿尔茨海默病概念上涨0.44%。4月28日的资金流向数据方面，主力资金净流入902.58万元，占总成交额5.1%，游资资金净流出758.45万元，占总成交额4.28%，散户资金净流出144.13万元，占总成交额0.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900034313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631531009","title":"图解*ST双成一季报：第一季度单季净利润同比增长134.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631531009","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631531009?lang=zh_cn&edition=full","pubTime":"2026-04-29 05:32","pubTimestamp":1777411961,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成2026年一季报显示，一季度公司主营收入4843.99万元，同比上升32.08%；归母净利润344.82万元，同比上升134.34%；扣非净利润285.38万元，同比上升125.73%；负债率48.55%，投资收益-0.01万元，财务费用393.74万元，毛利率62.35%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900012453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630583717","title":"*ST双成（002693）披露2026年一季度报告，4月28日股价上涨3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630583717","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630583717?lang=zh_cn&edition=full","pubTime":"2026-04-28 22:18","pubTimestamp":1777385881,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，*ST双成报收于9.06元，较前一交易日上涨3.07%，最新总市值为37.57亿元。该股当日开盘8.78元，最高9.23元，最低8.71元，成交额达1.77亿元，换手率为4.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800064988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628774105","title":"*ST双成（002693）披露关于申请撤销退市风险警示的公告，4月20日股价上涨1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628774105","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628774105?lang=zh_cn&edition=full","pubTime":"2026-04-20 18:20","pubTimestamp":1776680429,"startTime":"0","endTime":"0","summary":"海南双成药业股份有限公司于近日披露《关于申请撤销退市风险警示的公告》。公告显示，公司因2024年度经审计的净利润为负且扣除后的营业收入低于3亿元，股票自2025年4月30日起被实施退市风险警示。2026年4月16日，公司召开董事会审议通过申请撤销退市风险警示的议案。根据2025年度经审计财务数据，公司利润总额、净利润、扣非后净利润均为正值，营业收入为27,676.12万元，净资产为41,245.74万元，符合撤销退市风险警示条件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260420/32157506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628754080","title":"*ST双成（002693）2025年年报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2628754080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628754080?lang=zh_cn&edition=full","pubTime":"2026-04-19 06:13","pubTimestamp":1776550395,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期*ST双成发布2025年年报。截至本报告期末，公司营业总收入2.77亿元，同比上升58.87%，归母净利润1904.32万元，同比上升124.32%。本报告期*ST双成应收账款上升，应收账款同比增幅达419.5%。去年的净利率为3.22%，算上全部成本后，公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628073269","title":"*ST双成(002693)3月31日股东户数3.22万户，较上期减少16.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628073269","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628073269?lang=zh_cn&edition=full","pubTime":"2026-04-18 17:06","pubTimestamp":1776503168,"startTime":"0","endTime":"0","summary":"证券之星消息，近日*ST双成披露，截至2026年3月31日公司股东户数为3.22万户，较12月31日减少6483.0户，减幅为16.75%。在化学制药行业个股中，*ST双成股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.53万户。从股价来看，2025年12月31日至2026年3月31日，*ST双成区间涨幅为14.51%，在此期间股东户数减少6483.0户，减幅为16.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800018728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628785619","title":"图解*ST双成年报：第四季度单季净利润同比增长153.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628785619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628785619?lang=zh_cn&edition=full","pubTime":"2026-04-18 01:09","pubTimestamp":1776445753,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成2025年年报显示，当年度公司主营收入2.77亿元，同比上升58.87%；归母净利润1904.32万元，同比上升124.32%；扣非净利润1522.77万元，同比上升121.24%；其中2025年第四季度，公司单季度主营收入1.08亿元，同比上升128.29%；单季度归母净利润2156.66万元，同比上升153.29%；单季度扣非净利润2109.38万元，同比上升166.37%；负债率49.07%，投资收益56.27万元，财务费用1045.58万元，毛利率54.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800002340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628788919","title":"*ST双成(002693.SZ)：2025年净利润1904.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628788919","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628788919?lang=zh_cn&edition=full","pubTime":"2026-04-17 23:47","pubTimestamp":1776440821,"startTime":"0","endTime":"0","summary":"格隆汇4月17日丨*ST双成(002693.SZ)公布2025年年度报告，报告期内，公司实现营业收入27,676.12万元，同比增长58.87%；实现归属于上市公司股东的净利润1,904.32万元，同比增长124.32%。报告期内，公司研发的复杂制剂注射用紫杉醇(白蛋白结合型)获得美国FDA的上市许可批准并已上市销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260417/32152800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627429688","title":"*ST双成（002693）披露公司股票可能被终止上市的第六次风险提示性公告，4月16日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627429688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627429688?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:26","pubTimestamp":1776331603,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，*ST双成报收于8.36元，较前一交易日上涨0.36%，最新总市值为34.67亿元。海南双成药业股份有限公司于2026年4月16日发布《关于公司股票可能被终止上市的第六次风险提示性公告》。公告显示，公司股票已于2025年4月30日起被实施退市风险警示。若公司2025年年度报告披露后触及经审计的利润总额、净利润、扣除非经常性损益后的净利润三者孰低为负值且扣除后的营业收入低于3亿元等情形之一，公司股票将面临被终止上市的风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600031572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624265153","title":"*ST双成（002693）披露公司股票可能被终止上市的第五次风险提示性公告，4月3日股价下跌3.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624265153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624265153?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:04","pubTimestamp":1775210663,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，*ST双成报收于7.68元，较前一交易日下跌3.27%，最新总市值为31.85亿元。该股当日开盘7.9元，最高8.01元，最低7.62元，成交额达6890.33万元，换手率为2.17%。海南双成药业股份有限公司于近日发布《关于公司股票可能被终止上市的第五次风险提示性公告》。根据深交所规定，若2025年度报告披露后触及相关终止上市情形之一，公司股票将面临被终止上市的风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621315970","title":"异动快报：*ST双成（002693）3月24日9点37分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2621315970","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621315970?lang=zh_cn&edition=full","pubTime":"2026-03-24 09:41","pubTimestamp":1774316479,"startTime":"0","endTime":"0","summary":"证券之星3月24日盘中消息，9点37分*ST双成触及涨停板。其所属行业化学制药目前上涨。领涨股为富祥药业。该股为化学原料药，肝炎概念，医药概念热股，当日化学原料药概念上涨2.14%，肝炎概念概念上涨2.09%，医药概念上涨2.03%。3月23日的资金流向数据方面，主力资金净流出924.85万元，占总成交额8.5%，游资资金净流入81.73万元，占总成交额0.75%，散户资金净流入843.12万元，占总成交额7.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400008768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621270478","title":"*ST双成（002693）披露召开2026年第二次临时股东大会通知，3月23日股价下跌4.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621270478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621270478?lang=zh_cn&edition=full","pubTime":"2026-03-23 22:30","pubTimestamp":1774276239,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，*ST双成报收于7.61元，较前一交易日下跌4.04%，最新总市值为31.56亿元。近日，海南双成药业股份有限公司发布《关于召开2026年第二次临时股东会的通知》。公告显示，公司将于2026年4月8日召开2026年第二次临时股东会，会议由董事会召集，现场会议时间为当日14:30，网络投票时间为当日9:15至15:00。其中，第一项议案涉及关联交易，关联股东需回避表决；第三项为特别决议议案，须经出席会议股东所持表决权的三分之二以上通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300039916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620763781","title":"*ST双成（002693）披露2025年年度报告编制及最新审计进展情况公告，3月20日股价下跌1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620763781","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620763781?lang=zh_cn&edition=full","pubTime":"2026-03-20 17:23","pubTimestamp":1773998637,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，*ST双成报收于7.93元，较前一交易日下跌1.98%，最新总市值为32.88亿元。海南双成药业股份有限公司于近日发布《关于2025年年度报告编制及最新审计进展情况的公告》。公司预计2025年度净利润为正值且扭亏为盈，但最终数据以经审计的2025年年度报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000030232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620283741","title":"异动快报：*ST双成（002693）3月18日10点59分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2620283741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620283741?lang=zh_cn&edition=full","pubTime":"2026-03-18 11:01","pubTimestamp":1773802863,"startTime":"0","endTime":"0","summary":"证券之星3月18日盘中消息，10点59分*ST双成触及涨停板。其所属行业化学制药目前上涨。领涨股为莎普爱思。该股为半导体，医药，阿尔茨海默病概念热股，当日半导体概念上涨0.65%，医药概念上涨0.09%。3月17日的资金流向数据方面，主力资金净流出1325.95万元，占总成交额8.46%，游资资金净流入107.39万元，占总成交额0.69%，散户资金净流入1218.56万元，占总成交额7.78%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800015135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620170473","title":"*ST双成（002693）披露公司股票可能被终止上市的第四次风险提示性公告，3月17日股价下跌2.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620170473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620170473?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:23","pubTimestamp":1773757397,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，*ST双成报收于7.82元，较前一交易日下跌2.86%，最新总市值为32.43亿元。近日，海南双成药业股份有限公司发布《关于公司股票可能被终止上市的第四次风险提示性公告》。根据深交所规定，若2025年度报告披露后触及相关终止上市情形之一，公司股票将面临被终止上市的风险。公司已披露第四次风险提示公告，提醒投资者注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619396084","title":"异动快报：*ST双成（002693）3月16日13点25分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2619396084","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619396084?lang=zh_cn&edition=full","pubTime":"2026-03-16 13:30","pubTimestamp":1773639054,"startTime":"0","endTime":"0","summary":"证券之星3月16日盘中消息，13点25分*ST双成触及涨停板。其所属行业化学制药目前上涨。领涨股为新诺威。该股为半导体，肝炎概念，阿尔茨海默病概念热股，当日半导体概念上涨2.04%，肝炎概念概念上涨0.78%，阿尔茨海默病概念上涨0.65%。3月13日的资金流向数据方面，主力资金净流入740.69万元，占总成交额9.46%，游资资金净流出99.24万元，占总成交额1.27%，散户资金净流出641.45万元，占总成交额8.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600013838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619156127","title":"异动快报：*ST双成（002693）3月13日9点32分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2619156127","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619156127?lang=zh_cn&edition=full","pubTime":"2026-03-13 09:35","pubTimestamp":1773365751,"startTime":"0","endTime":"0","summary":"证券之星3月13日盘中消息，9点32分*ST双成（002693）触及涨停板。其所属行业化学制药目前下跌。领涨股为能特科技。该股为阿尔茨海默病，半导体，医药概念热股，当日阿尔茨海默病概念上涨0.04%。3月12日的资金流向数据方面，主力资金净流出19.88万元，占总成交额0.95%，游资资金净流入136.54万元，占总成交额6.56%，散户资金净流出116.66万元，占总成交额5.6%。近5日资金流向一览见下表：*ST双成主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300008987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616532114","title":"*ST双成（002693）披露公司股票可能被终止上市的第三次风险提示性公告，3月3日股价下跌3.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616532114","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616532114?lang=zh_cn&edition=full","pubTime":"2026-03-03 23:04","pubTimestamp":1772550259,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘，*ST双成报收于7.16元，较前一交易日下跌3.11%，最新总市值为29.69亿元。近日，海南双成药业股份有限公司发布《关于公司股票可能被终止上市的第三次风险提示性公告》。根据相关规定，若公司2025年度报告出现经审计的利润为负且扣除后营收低于3亿元、净资产为负或财务报告被出具非标意见等情形之一，公司股票将面临终止上市风险。公司已披露三次风险提示公告，最终财务数据以经审计的2025年年度报告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300044868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607087893","title":"*ST双成：公司目前没有生物方面的研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2607087893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607087893?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:51","pubTimestamp":1769691102,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)01月28日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司在生物方面有哪些研究？*ST双成回复：尊敬的投资者您好，公司目前没有生物方面的研究，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900040890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777721542186,"stockEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0765},{"period":"3month","weight":0.1517},{"period":"6month","weight":0.0313},{"period":"1year","weight":0.0593},{"period":"ytd","weight":0.2328}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0566},{"period":"3month","weight":-0.0014},{"period":"6month","weight":0.0398},{"period":"1year","weight":0.2541},{"period":"ytd","weight":0.0361}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南双成药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"32225人(较上一季度减少16.75%)","perCapita":"12753股","listingDate":"2012-08-08","address":"海南省海口市秀英区兴国路16号","registeredCapital":"41468万元","survey":" 海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用紫杉醇（白蛋白结合型）、注射用胸腺法新、注射用生长抑素、注射用比伐芦定、依替巴肽注射液、醋酸奥曲肽注射液。","listedPrice":20},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"*ST双成(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供*ST双成(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"*ST双成,002693,*ST双成股票,*ST双成股票老虎,*ST双成股票老虎国际,*ST双成行情,*ST双成股票行情,*ST双成股价,*ST双成股市,*ST双成股票价格,*ST双成股票交易,*ST双成股票购买,*ST双成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"*ST双成(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供*ST双成(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}